Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease
NCT00113009
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
148
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Vascular Disease
Interventions
DRUG:
VLTS-934
Sponsor
Valentis